(Q61479920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Analysis of the discontinuation of protease inhibitor therapy in routine clinical practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

E Ferrer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Consiglio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Podzamczer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J M Ramon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J L Perez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Gudiol

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Infectious Diseases

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

495-499

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

Protease inhibitors in the homeless

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365549950164030

10.1080/00365549950164030

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10576130%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference